rheumatoid arthritis
GSK expands inflammatory alliance
March 12, 2010Research and Development Cellzome, GlaxoSmithKline, rheumatoid arthritis
GlaxoSmithKline has formed a second strategic alliance with Cellzome to research new treatments for inflammatory diseases. GSK will buy into …
Roche halts ocrelizumab trials
March 8, 2010Research and Development RoActemra, ocrelizumab, rheumatoid arthritis
The future of Roche and Biogen Idec’s rheumatoid arthritis drug ocrelizumab has been thrown into doubt after the manufacturers decided …
AstraZeneca signs deal with Rigel on RA treatment
February 17, 2010Research and Development AZ, Rigel, rheumatoid arthritis
AstraZeneca is looking to enter the lucrative rheumatoid arthritis market by in-licensing a phase II treatment.The global market for rheumatoid …
Orencia wins expanded European licence
January 27, 2010Sales and Marketing BMS, Orencia, rheumatoid arthritis
BMS’s Orencia has been approved in Europe to treat children aged six and over who suffer from a form of …
Patient access scheme secures NICE approval for Cimzia
January 22, 2010Sales and Marketing Cimzia, NICE, UCB, rheumatoid arthritis
UCB Pharma’s Cimzia has been recommended by NICE to treat rheumatoid arthritis – but only if a patient access scheme …
FDA approves Roche’s Actemra
January 11, 2010Sales and Marketing Actemra, RoActemra, Roche, US, rheumatoid arthritis
Roche’s Actemra has been approved in the US for the treatment of moderately to severely active rheumatoid arthritis (RA) and …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
